Aura Biosciences FY 2023 EPS $(1.93) Misses $(1.82) Estimate
Portfolio Pulse from Benzinga Newsdesk
Aura Biosciences reported a FY 2023 EPS of $(1.93), missing the consensus estimate of $(1.82) by 6.04%. This represents a slight improvement over the previous year's loss of $(1.96) per share.

March 27, 2024 | 11:14 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Aura Biosciences reported a larger than expected loss for FY 2023, missing analyst estimates.
Missing the EPS estimate by 6.04% and reporting a larger loss than expected could lead to negative investor sentiment in the short term. Although there's a slight improvement from the previous year, the miss may overshadow this positive aspect.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100